Skip to main content
Recall Canary
Fluphenazine HCl Tablets 1mg
← Back to all recalls
DRUG RECALLLOW

Fluphenazine HCl Tablets 1mg

Ajanta Pharma recalls Fluphenazine HCl 1mg tablets (NDC 27241-255-01) due to impurity out-of-specification.

What to do

Consult your healthcare provider to obtain a replacement or alternative medication. Continue taking the medication unless your provider advises otherwise, and return the affected product to the pharmacy.

Recalled
Listed
Updated
Agency
FDA
Firm
Ajanta Pharma USA Inc
Recall ID
99733
Status
ONGOING

Recall at a glance

Quantity recalled
403,200 tablets

Why it was recalled

Ajanta Pharma USA is recalling Fluphenazine Hydrochloride Tablets, USP, 1mg, 100-count bottles, because the product failed impurity specifications. Testing at the 18-month long-term stability point found an out-of-specification result for organic impurities (Impurity-A) at 1.1% versus the 1.0% specification limit. Patients should continue taking their medication and consult their healthcare provider for alternatives.

Is mine affected?

Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.

Fluphenazine Hydrochloride Tablets, USP

Lot code
DJ23254, 2026
Strength
1 mg
NDC / UPC
NDC 27241-255-01

Timeline

  1. Firm initiated recall
  2. Publicly announced
  3. Listed on Recall Canary
  4. Summary updated

Other recent recalls from Ajanta Pharma USA Inc

All recalls from Ajanta Pharma USA Inc

← Back to all recalls

Editorial summary by Recall Canary · summary updated 2026-09-09 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification